Daniel S. Lorrain insider trades

Open-market stock purchases and sales by Daniel S. Lorrain, Chief Scientific Officer at Contineum Therapeutics, Inc, from SEC Form 4 filings since May 24, 2024.

Recent trades

DateStockTradeValue
Jul 9, 2026CTNM Contineum Therapeutics, IncSold$400
Jul 9, 2026CTNM Contineum Therapeutics, IncBought (not open market)$25
Jul 9, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Jul 8, 2026CTNM Contineum Therapeutics, IncSold$16.2K
Jul 8, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Jul 8, 2026CTNM Contineum Therapeutics, IncBought (not open market)$1K
Jul 1, 2026CTNM Contineum Therapeutics, IncSold$91.7K
Jul 1, 2026CTNM Contineum Therapeutics, IncSold$40.6K
Jul 1, 2026CTNM Contineum Therapeutics, IncBought (not open market)$4.2K
Jul 1, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Jun 30, 2026CTNM Contineum Therapeutics, IncSold$462K
Jun 30, 2026CTNM Contineum Therapeutics, IncBought (not open market)$29.1K
Jun 30, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Jun 1, 2026CTNM Contineum Therapeutics, IncSold$54.9K
May 1, 2026CTNM Contineum Therapeutics, IncSold$50.5K
May 1, 2026CTNM Contineum Therapeutics, IncSold$4.2K
Apr 6, 2026CTNM Contineum Therapeutics, IncSold$56K
Mar 2, 2026CTNM Contineum Therapeutics, IncSold$62.6K
Feb 25, 2026CTNM Contineum Therapeutics, IncSold$61.2K
Feb 25, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Feb 24, 2026CTNM Contineum Therapeutics, IncSold$68.9K
Feb 24, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Feb 19, 2026CTNM Contineum Therapeutics, IncSold$1.6K
Feb 19, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Feb 11, 2026CTNM Contineum Therapeutics, IncSold$6.4K

Companies traded

  • CTNM Contineum Therapeutics, Inc: 22 sales, last Jul 9, 2026

Get free alerts when Daniel S. Lorrain files a new trade →